Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Tangible Net Worth Ratio

Latest as of March 2026: 90.9%

Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Tangible Net Worth Ratio of 90.9% as of March 2026. This metric is calculated by deducting intangible assets (CN¥835.05 Million) from net assets (CN¥9.20 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Zhejiang Hisun Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

90.9%
Tangible equity / total equity

Net Assets (Equity)

CN¥9.20 Billion
CNY

Intangible Assets

CN¥835.05 Million
Goodwill, patents, brand value

Total Assets

CN¥13.81 Billion
CNY

Zhejiang Hisun Pharmaceutical Co Ltd Tangible Net Worth Ratio (1997–2025)

This chart shows how Zhejiang Hisun Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 90.9%, reflecting net assets of CN¥9.20 Billion with intangible assets of CN¥835.05 Million CNY. See Zhejiang Hisun Pharmaceutical Co Ltd (600267) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Zhejiang Hisun Pharmaceutical Co Ltd (1997–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Hisun Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Zhejiang Hisun Pharmaceutical Co Ltd.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 90.4% CN¥8.85 Billion CN¥850.48 Million CN¥15.05 Billion ▲ +2.0 pp
2024 88.4% CN¥8.58 Billion CN¥994.63 Million CN¥15.97 Billion ▲ +3.3 pp
2023 85.1% CN¥8.35 Billion CN¥1.24 Billion CN¥17.61 Billion ▲ +3.4 pp
2022 81.7% CN¥8.33 Billion CN¥1.52 Billion CN¥18.78 Billion ▲ +3.4 pp
2021 78.3% CN¥7.35 Billion CN¥1.59 Billion CN¥19.37 Billion ▼ -5.4 pp
2020 83.8% CN¥8.26 Billion CN¥1.34 Billion CN¥20.86 Billion ▲ +1.3 pp
2019 82.4% CN¥7.68 Billion CN¥1.35 Billion CN¥21.47 Billion ▲ +14.9 pp
2018 67.5% CN¥7.38 Billion CN¥2.40 Billion CN¥21.85 Billion ▼ -9.3 pp
2017 76.8% CN¥7.88 Billion CN¥1.83 Billion CN¥21.64 Billion ▼ -4.6 pp
2016 81.4% CN¥8.04 Billion CN¥1.50 Billion CN¥20.76 Billion ▼ -4.5 pp
2015 85.9% CN¥8.17 Billion CN¥1.15 Billion CN¥19.17 Billion ▼ -4.5 pp
2014 90.5% CN¥8.26 Billion CN¥787.55 Million CN¥17.30 Billion ▲ +1.6 pp
2013 88.9% CN¥5.96 Billion CN¥661.54 Million CN¥13.97 Billion ▼ -0.8 pp
2012 89.7% CN¥5.20 Billion CN¥535.95 Million CN¥10.57 Billion ▼ 0.0 pp
2011 89.7% CN¥4.59 Billion CN¥473.64 Million CN¥8.23 Billion ▲ +3.6 pp
2010 86.0% CN¥2.74 Billion CN¥382.88 Million CN¥5.92 Billion ▲ +0.9 pp
2009 85.1% CN¥2.43 Billion CN¥361.28 Million CN¥5.20 Billion ▲ +1.1 pp
2008 84.0% CN¥1.55 Billion CN¥247.96 Million CN¥4.12 Billion ▼ -3.3 pp
2007 87.3% CN¥1.38 Billion CN¥174.54 Million CN¥2.99 Billion ▼ -8.9 pp
2006 96.3% CN¥1.27 Billion CN¥47.37 Million CN¥2.81 Billion ▲ +0.4 pp
2005 95.9% CN¥1.23 Billion CN¥50.15 Million CN¥2.61 Billion ▲ +0.5 pp
2004 95.4% CN¥1.20 Billion CN¥55.30 Million CN¥2.18 Billion ▲ +1.6 pp
2003 93.8% CN¥1.00 Billion CN¥62.55 Million CN¥1.87 Billion ▲ +2.6 pp
2002 91.1% CN¥824.83 Million CN¥73.05 Million CN¥1.58 Billion ▼ -1.5 pp
2001 92.7% CN¥784.18 Million CN¥57.31 Million CN¥1.30 Billion ▼ -0.8 pp
2000 93.5% CN¥757.90 Million CN¥48.97 Million CN¥1.21 Billion ▲ +11.8 pp
1999 81.8% CN¥249.88 Million CN¥45.59 Million CN¥672.12 Million ▲ +5.4 pp
1998 76.3% CN¥196.50 Million CN¥46.56 Million CN¥483.70 Million ▼ -23.7 pp
1997 100.0% CN¥184.23 Million CN¥36.00K CN¥352.91 Million
pp = percentage points